FastForward Innovations has subscribed $2m for an approximate 0.8% equity interest in Juvenescence, a British Virgin Islands incorporated private company developing therapies to slow, halt and potentially reverse ageing, it announced on Tuesday. The AIM-traded firm said it subscribed as part of a $50m Series A fundraise that Juvenescence had now closed, with a post-money valuation of $250m. It said the Juvenescence founders and management team had an "extensive" track record of successfully ...Den vollständigen Artikel lesen ...
© 2018 LiveCharts.co.uk